In this open-label , randomized controlled trial , 206 general medicine and surgery patients with type 2 diabetes treated with a basal-bolus regimen were randomized to receive either supplemental insulin ( n = 106 ) at bedtime for blood glucose ( BG ) > 7.8 mmol/L or no supplemental insulin ( n = 100 ) except for BG > 19.4 mmol/L .